Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Secondary Prevention of Small Subcortical Strokes (SPS3) Trial

Next Previous
Trial Profile

Secondary Prevention of Small Subcortical Strokes (SPS3) Trial

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 10 Mar 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clopidogrel (Primary) ; Aspirin
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms SPS3

    • Most Recent Events

    • 06 Mar 2023 Results of post hoc analysis (n=2874) assessing the rate of persistent smoking after ischemic stroke and the association between smoking status and major cardiovascular outcomes published in the Stroke
    • 22 Jan 2021 Results (n=942) assessing relationship between A1C and cognitive function in lacunar stroke patients with diabetes, published in the Journal of Clinical Endocrinology and Metabolism.
    • 20 Jul 2017 Results (n=2916) assessing cognitive function, presented at the Alzheimer's Association International Conference 2017.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top